Mesima
At a glance
- Best for
- people seeking a traditional immune-support mushroom, accepting weak evidence
- Typical dose
- Label-directed extract, commonly 1–3 g/day
- Time to effect
- Unclear
- Main caution
- Not a cancer treatment; limited human safety data
What is it
Mesima (Phellinus linteus) is a medicinal mushroom used in East Asian traditional medicine, sold as an extract rich in polysaccharides and beta-glucans. It is marketed mainly for immune support and as a complementary agent in cancer care. Human evidence is very limited, with most data coming from laboratory and animal studies.
Is it worth it for you?
Worth considering if…
- You want a traditional mushroom extract and have realistic expectations
- You will use it only as a supplement, not a treatment
Probably skip if…
- You expect it to treat or prevent cancer
- You are on immunosuppressants or chemotherapy without oncology guidance
- You want evidence from controlled human trials
Evidence at a glance
| Goal | Evidence | Effect | Best fit | Time |
|---|---|---|---|---|
| immune support | Mixed Evidence | Unclear | adults seeking general immune support with modest expectations | Unclear |
Evidence for 1 use
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
immune support
Mechanism onlyPhellinus linteus polysaccharides modulate immune cells and show antitumor activity in cell and animal models, which underpins its traditional reputation. Robust human trials demonstrating clinical immune benefit are lacking, and existing human reports are small or anecdotal. Claims should be limited to mechanism, not proven outcomes.
Bottom line: Immune effects are shown only in lab and animal models, not in controlled human studies.
Evidence is mixed
Strong preclinical signals are not matched by human trial evidence, so clinical benefit is unproven.
How to take it
- Typical dose
- 1–3 g/day standardized extract per label
- Timing
- With meals
- With food
- With food
- How long to try
- No established trial duration; reassess periodically
What to track
- General tolerance and GI symptoms
- Any allergic reaction
Safety
Common side effects
GI upset
Serious risks
- Rare reports of hypersensitivity/pneumonitis with some medicinal mushrooms
Who should avoid it
- People on immunosuppressive therapy without medical advice
- People with mushroom allergy
- Pregnant or breastfeeding people
Pregnancy & breastfeeding
Avoid; safety has not been established.
Interactions
Immune-modulating effects could theoretically oppose immunosuppressive therapy
Choosing a product
Look for
- Species Phellinus linteus confirmed
- Beta-glucan/polysaccharide content stated
- Fruit body vs mycelium disclosed
- Third-party testing
Be skeptical of
- Cures or treats cancer
- Replaces medical therapy
- Guaranteed immune boost
References by claim
immune support
- Zhu et al., 2008 — PubMed (2008) link
Track Mesima with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.